LFFLX
Price
$13.95
Change
-$0.02 (-0.14%)
Updated
Jun 5 closing price
Net Assets
36.05M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

LFFLX vs RMEBX

Header iconLFFLX vs RMEBX Comparison
Open Charts LFFLX vs RMEBXBanner chart's image
Lord Abbett Focused Large Cap Value F
Price$13.95
Change-$0.02 (-0.14%)
VolumeN/A
Net Assets36.05M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
LFFLX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LFFLX vs. RMEBX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFFLX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. LFFLX (36M). RMEBX pays higher dividends than LFFLX: RMEBX (1.16) vs LFFLX (0.76). LFFLX was incepted earlier than RMEBX: LFFLX (6 years) vs RMEBX (11 years). LFFLX (1.49) is less costly to investors than RMEBX (1.07). LFFLX is a more actively managed with annual turnover of: 58.00 vs. RMEBX (31.00). LFFLX has a lower initial minimum investment than RMEBX: LFFLX (0) vs RMEBX (250). LFFLX annual gain was more profitable for investors over the last year : 11.97 vs. RMEBX (8.30). RMEBX return over 5 years is better than : 49.85 vs. LFFLX (1.40).
LFFLXRMEBXLFFLX / RMEBX
Total Expense Ratio0.711.0766%
Annual Report Gross Expense Ratio1.491.07139%
Fund Existence6 years11 years-
Gain YTD4.2545.34980%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets36M105B0%
Annual Yield % from dividends0.761.1666%
Returns for 1 year11.978.30144%
Returns for 3 years-5.4817.96-30%
Returns for 5 years1.4049.853%
Returns for 10 yearsN/A68.21-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA